These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7742288)

  • 21. Potential bacterial contamination of eyedrops used for tonometry.
    Palmberg R; Gutierrez YS; Miller D; Feuer WJ; Anderson DR
    Am J Ophthalmol; 1994 May; 117(5):578-82. PubMed ID: 8172262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of microbial contamination in multi-dose fluorescein eyedrops in a reference eye center.
    Costa CM; Espósito KP; Florêncio VMB; Aquino PRL; Firmo EF; Costa IMDA; Rocha C; Andrade CG; Oliveira-Júnior JB; Ventura CV
    Arq Bras Oftalmol; 2021; 84(5):449-453. PubMed ID: 34550217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects].
    Sauer R; Blüthner K; Seitz B
    Ophthalmologe; 2004 Jul; 101(7):705-9. PubMed ID: 14999414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbial Cross-contamination in Multidose Eyedrops: The Impact of Instillation Angle and Bottle Geometry.
    da Costa AX; Yu MCZ; de Freitas D; Cristovam PC; LaMonica LC; Dos Santos VR; Gomes JAP
    Transl Vis Sci Technol; 2020 Jun; 9(7):7. PubMed ID: 32832214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use conditions of boric acid solution in the eye: handling and occurrence of contamination].
    José AC; Castelo Branco B; Ohkawara LE; Yu MC; Lima AL
    Arq Bras Oftalmol; 2007; 70(2):201-7. PubMed ID: 17589687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of multidose vial contamination by aerobic bacteria in a major teaching hospital, Shiraz, Iran, 2006.
    Motamedifar M; Askarian M
    Am J Infect Control; 2009 Nov; 37(9):773-7. PubMed ID: 19362388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular surface changes in glaucoma patients related to topical medications.
    Kovačević S; Čanović S; Pavičić AD; Kolega MŠ; Bašić JK
    Coll Antropol; 2015 Mar; 39(1):47-9. PubMed ID: 26040067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients.
    Doğan AS; Orhan M; Söylemezoğlu F; Irkeç M; Bozkurt B
    Clin Exp Ophthalmol; 2004 Feb; 32(1):62-6. PubMed ID: 14746595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacterial contamination of eyedrops in clinical use].
    Raynaud C; Laveran H; Rigal D; Bonicel P
    J Fr Ophtalmol; 1997; 20(1):17-24. PubMed ID: 9099279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research and correlation analysis on the dripper contamination of carteolol hydrochloride eye drops.
    Wang YM; Ren YL; Xu J; Zhang XF
    Ann Palliat Med; 2021 Jun; 10(6):6779-6785. PubMed ID: 34154346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension].
    Van Went C; Alalwani H; Brasnu E; Pham J; Hamard P; Baudouin C; Labbé A
    J Fr Ophtalmol; 2011 Dec; 34(10):684-90. PubMed ID: 22093372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial contamination in soft contact lens wearers.
    Lipener C; Nagoya FR; Zamboni FJ; Lewinski R; Kwitko S; Uras R
    CLAO J; 1995 Apr; 21(2):122-4. PubMed ID: 7796522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles.
    Moore DB; Hammer JD; Akhtari R; Beck J; Sanders S; Kryscio RJ
    J Glaucoma; 2016 Sep; 25(9):780-4. PubMed ID: 27552516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of Eyedrop Volume for Topical Ophthalmic Medications with the Nanodropper Bottle Adaptor.
    St Peter DM; Steger JS; Patnaik JL; Davis N; Kahook MY; Seibold LK
    Med Devices (Auckl); 2023; 16():71-79. PubMed ID: 37056302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial Contamination and Antimicrobial Resistance in Use of Ophthalmic Solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia.
    Tamrat L; Gelaw Y; Beyene G; Gize A
    Can J Infect Dis Med Microbiol; 2019; 2019():5372530. PubMed ID: 31178944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial contamination of single- and multiple-dose vials after opening in a pulmonary teaching hospital.
    Baniasadi S; Dorudinia A; Mobarhan M; Karimi Gamishan M; Fahimi F
    Braz J Infect Dis; 2013; 17(1):69-73. PubMed ID: 23294643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improper topical self-administration of ocular medication among patients with glaucoma.
    Brown MM; Brown GC; Spaeth GL
    Can J Ophthalmol; 1984 Feb; 19(1):2-5. PubMed ID: 6608974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal Effects on the Corneoconjunctival Microflora in a Population of Persian Cats in Iran.
    Aftab G; Rajaei SM; Pot SA; Faghihi H
    Top Companion Anim Med; 2019 Mar; 34():30-32. PubMed ID: 30808494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.